Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309749 · ClinicalTrials.gov registry record
CAP Pilot Study for Obstructive Sleep Apnea (OSA)
A clinical trial, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- 50
- Enrollment target
NCT02309749 is a clinical trial that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 50 participants.
The verdict
NCT02309749 has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.
Interventions
- OTHER CAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02309749
The ClinicalTrials.gov registry entry for NCT02309749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAP is the first listed.
NCT02309749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02309749 about?
NCT02309749 is a clinical study titled "CAP Pilot Study for Obstructive Sleep Apnea (OSA)". This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours pe...
What is the current status of trial NCT02309749?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02309749?
The interventions under investigation include: CAP (OTHER).
Who is sponsoring clinical trial NCT02309749?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.